The FDA Has a New Drug Chief. What it Means for Biotech Stocks.

Dr. Richard Pazdur is “likely the best possible person for the role,” says one analyst. A calmer course for the FDA could add ...

RFK Jr. discussed scaling back the role of FDA chief Makary, WSJ reports

Trump administration officials, including Health Secretary Robert F. Kennedy Jr., have discussed scaling back the role of ...

FDA’s plan to boost biosimilar drugs could stall at the patent office

In the past, biosimilar makers have been able to invalidate some of those patents through a sped-up process called “inter ...
The Manila Times

Spryte Medical Receives FDA IDE Approval to Initiate "INSYTE” US Pivotal Trial evaluating the nOCT Imaging System during Brain Aneurysm Treatment

Spryte Medical, a pioneer in intravascular neuro imaging, announced it has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to initiate the ...

Onepot AI raises $13M to help make chemical drug creation easier

“The best ideas in drug discovery were often blocked not by biology, but by synthesis,” Boiko told TechCrunch. Synthesis is ...
STAT

Pharmalittle: We’re reading about a Novo drug and Alzheimer’s, a Sarepta drug warning, and more

Novo Nordisk is expected to announce soon whether its blockbuster GLP-1 drug semaglutide can help slow Alzheimer’s disease ...

New Book Shows How The Right Culture And Strategy Drive Breakthroughs In Drug And Device Development

How People, Process, and Systems Transform the Business of Life Sciences” by Gary K. Zammit, PhD, is released with Forbes ...
Medscape

Can New Drug Herald Shorter TB Treatment?

Clinical trial results found that a new antibiotic candidate could shorten TB treatment from the standard 6 months to 8 weeks ...

Ozempic price slashed and set to reshape the obesity drug market

Novo Nordisk A/S is undercutting archrival Eli Lilly & Co. on obesity drugs for cash-pay patients, showing its willingness to ...